Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying and developing novel treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include Tebipenem HBr (tebipenem pivoxil...
57 insider purchases on record · latest filing 2022-04-28.
Insiders have also filed 83 sale transactions at SPRO.